|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-1-10
|
|
pubmed:abstractText |
The evidence of clinical value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) in lymph node (LN) staging in non-small cell lung cancer (NSCLC) has been shown in numerous papers. However, few studies have assessed its limitations. The aim of the present study is to clarify clinico-pathologic factors responsible for false PET results.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
235-42
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15639722-Adult,
pubmed-meshheading:15639722-Aged,
pubmed-meshheading:15639722-Aged, 80 and over,
pubmed-meshheading:15639722-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:15639722-False Negative Reactions,
pubmed-meshheading:15639722-Female,
pubmed-meshheading:15639722-Fluorodeoxyglucose F18,
pubmed-meshheading:15639722-Humans,
pubmed-meshheading:15639722-Inflammation,
pubmed-meshheading:15639722-Lung Neoplasms,
pubmed-meshheading:15639722-Lymphatic Metastasis,
pubmed-meshheading:15639722-Male,
pubmed-meshheading:15639722-Middle Aged,
pubmed-meshheading:15639722-Neoplasm Staging,
pubmed-meshheading:15639722-Positron-Emission Tomography,
pubmed-meshheading:15639722-Radiopharmaceuticals,
pubmed-meshheading:15639722-Sensitivity and Specificity
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
|
|
pubmed:affiliation |
Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan. ktakamoc@hama-med.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
